EPTRI conference in Bari, April 10, 2018

On April 10, 2018 the University of Bari will host the EPTRI meeting “A new research infrastructure for the development of new paediatric drugs”.

The representatives of the Italian institutions promoting EPTRI and the project partners will participate in this event, aimed to give all participants a better understanding of the tasks and goals of the project and to illustrate the key elements of the new research infrastructure. The first part of the meeting will be focused on the global scenario around EPTRI and the role of RIs to strengthening research outcomes to improve patients’ health. The second part of the meeting will be dedicated to the presentation of the technical component of the infrastructure, with a particular focus on the operational plans of the five thematic platforms composing EPTRI as well as the importance of the patient engagement.

ID-EPTRI (European Paediatric Translational Research Infrastructure) is a new complementary Research Infrastructure (RI) intended to putting together and networking all the available competences and technologies useful to enhance paediatric research in paediatric medicines from drug discovery and early development phases to be translated into clinical phases and medicines uses.

Funded within the H2020-INFRADEV-01-2017 programme and officially launched in Rome last January, EPTRI aims to design the framework for the new RI providing a conceptual design report (CDR) of EPTRI describing the scientific and technical requirements as well as the key components of the new RI.

The project ID-EPTRI is coordinated by Consorzio per Valutazioni Biologiche e Farmacologiche, of which the Benzi Foundation is third party in this project, and involves 26 partners from 19 EU and and non-European countries including existing RIs, the major paediatric expertise to cover the scientific topics in the proposal, previous expertise and collaborative resources and partners outside Europe.

Download the meeting agenda.

Torna all'inizio
« Indietro
Comments are closed.